EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa

Amine Souadka, Hajar Habbat, Amin Makni, Mourad Abid, Zakaria El Mouatassim iD, Amin Daghfous, Zakia Korjani, Wael Rebai, Mouna Ayadi, Wafa Hania Messai, Mohammed Anass Majbar iD, Amine Benkabbou und 2 weitere

Cancers · 24.06.2025 · 17 (13) · 2113

DOI: 10.3390/cancers17132113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 24.06.2025. Verfasst von Amine Souadka und 13 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology Department, National Institute of Oncology, Mohammed V University, Rabat 10000, Morocco. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Cancer Research Institute IRC”, Kingdom of Morocco.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peritoneal surface malignancies (PSM) are aggressive cancers with limited treatment access in low- and middle-income countries (LMICs). While cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have improved survival outcomes globally, their feasibility in LMICs remains underexplored. This first multicenter study in North Africa evaluates the implementation and outcomes of CRS with or without HIPEC in resource-limited settings.

Methods

A retrospective cohort study of 391 patients with PSM (colorectal cancer, pseudomyxoma peritonei, ovarian cancer, gastric cancer, or mesothelioma) treated with CRS ± HIPEC between 2014 and 2020 at four tertiary centers in Morocco, Tunisia, and Algeria. Primary outcomes included overall survival (OS), disease-free survival (DFS), and severe postoperative morbidity (Clavien-Dindo ≥ IIIa). Cox regression was used to identify independent prognostic factors.

Results

Among 391 patients, complete cytoreduction (CC-0/1) was achieved in 88%, and HIPEC was performed in 39%. Severe morbidity occurred in 22%, with HIPEC, spleno-pancreatectomy, and incomplete cytoreduction (CC-2) identified as significant risk factors. The median OS was 68 months, with 1- and 5-year survival rates of 97% and 56%, respectively. Patients undergoing CRS + HIPEC had significantly longer OS than CRS alone (70 vs. 64 months, p = 0.016), though DFS was not significantly different between groups. Independent predictors of improved OS included HIPEC, CC score, PCI, and primary tumor type.

Conclusions

This first North African multicenter study establishes the feasibility and efficacy of CRS and HIPEC in LMICs, achieving survival outcomes comparable to high-income settings. The findings support expanding advanced PSM treatment programs in resource-limited settings, emphasizing structured training and multidisciplinary collaboration to improve access and outcomes.

Schlagwörter

Stichwörter der Autor:innen

cytoreductive surgery (CRS)hyperthermic intraperitoneal chemotherapy (HIPEC)low- and middle-income countries (LMIC)peritoneal surface malignancies (PSM)

Autor:innen und Institutionen

  • Surgical Oncology Department, National Institute of Oncology, Mohammed V University, Rabat 10000, Morocco.
  • Surgical Department A, Rabta Hospital, Tunis 1007, Tunisia.
  • Surgical Oncology Department, Batna Cancer Institute, Batna, Algeria.
  • Medical Oncology Department, Salah-Azaiz Institute, Tunis 1006, Tunisia.
  • Surgical Oncology Department, Private Oncology Center, Rabat, Morocco.

ORCID-Profile: Zakaria El Mouatassim, Mohammed Anass Majbar

Förderung

  • “Cancer Research Institute IRC”, Kingdom of Morocco

Zitieren

APA

Souadka, A., Habbat, H., Makni, A., Abid, M., El Mouatassim, Z., Daghfous, A., Korjani, Z., Rebai, W., Ayadi, M., Messai, W. H., Majbar, M. A., Benkabbou, A., Mohsine, R., & Souadka, A. (2025). Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa. Cancers, 17(13), 2113. https://doi.org/10.3390/cancers17132113

Vancouver

Souadka A, Habbat H, Makni A, Abid M, El Mouatassim Z, Daghfous A, et al. Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa. Cancers. 2025;17(13):2113. doi:10.3390/cancers17132113

BibTeX
@article{Souadka2025,
  author = {Souadka, Amine and Habbat, Hajar and Makni, Amin and Abid, Mourad and El Mouatassim, Zakaria and Daghfous, Amin and Korjani, Zakia and Rebai, Wael and Ayadi, Mouna and Messai, Wafa Hania and Majbar, Mohammed Anass and Benkabbou, Amine and Mohsine, Raouf and Souadka, Abdelilah},
  title = {Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2113},
  doi = {10.3390/cancers17132113}
}
Kostenlos starten →